The Stanford School of Medicine is working on multiple projects to address the urgent needs of the entire cystic fibrosis (CF) community. Lung problems are the most serious complications for kids with CF. Our pediatric team is working to identify the best ways to control infections and detect lung disease earlier to help all patients with CF. We’re also at the forefront of investigating CF treatment in utero.
Stanford’s unique focus on restoring mucus clearance to improve lung function and decrease lung damage has the potential to make a tremendous impact on patients who don’t respond to modulator therapy.
Our goal is to unlock the mysteries of this complex disease and drastically improve treatment options, leading to a better quality of life for all kids with CF. With your help, we can achieve this.



